LabVax

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameLabVax
Drug Alias NameLabvax 3(22)-23LabVax-3(22)-23
ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLabyrx Immunologic Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstituteLabyrx Immunologic Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursAdenocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A